Ch
Chroma Med
Cambridge MAFounded 201940 employees
Private CapbiotechPrivateGenetic Medicine
Platform: Epigenome Ctrl
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CHR-2584 | CHR-2584 | Phase 2 | 2 | TYK2 | Psoriasis | ||
| CHR-9224 | CHR-9224 | Phase 2 | 2 | Cl18.2 | OCD | ||
| CHR-2685 | CHR-2685 | Phase 2 | 1 | SGLT2 | Prostate Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)